- Home
- WKEY vs ALGS Comparison
WKEY vs ALGS Comparison
Compare WKEY & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- ALGS
- Stock Information
- Founded
- WKEY 1999
- ALGS 2018
- Country
- WKEY Switzerland
- ALGS United States
- Employees
- WKEY N/A
- ALGS N/A
- Industry
- WKEY EDP Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- ALGS Health Care
- Exchange
- WKEY Nasdaq
- ALGS Nasdaq
- Market Cap
- WKEY 58.9M
- ALGS 53.0M
- IPO Year
- WKEY N/A
- ALGS 2020
- Fundamental
- Price
- WKEY $8.77
- ALGS $10.51
- Analyst Decision
- WKEY Strong Buy
- ALGS Strong Buy
- Analyst Count
- WKEY 2
- ALGS 2
- Target Price
- WKEY $10.50
- ALGS $60.00
- AVG Volume (30 Days)
- WKEY 439.2K
- ALGS 100.3K
- Earning Date
- WKEY 09-23-2025
- ALGS 11-05-2025
- Dividend Yield
- WKEY N/A
- ALGS N/A
- EPS Growth
- WKEY N/A
- ALGS N/A
- EPS
- WKEY N/A
- ALGS N/A
- Revenue
- WKEY $11,994,000.00
- ALGS $3,174,000.00
- Revenue This Year
- WKEY $32.29
- ALGS N/A
- Revenue Next Year
- WKEY $89.83
- ALGS N/A
- P/E Ratio
- WKEY N/A
- ALGS N/A
- Revenue Growth
- WKEY N/A
- ALGS N/A
- 52 Week Low
- WKEY $1.61
- ALGS $3.76
- 52 Week High
- WKEY $14.00
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- WKEY 64.98
- ALGS 56.71
- Support Level
- WKEY $6.45
- ALGS $9.02
- Resistance Level
- WKEY $10.61
- ALGS $10.36
- Average True Range (ATR)
- WKEY 0.90
- ALGS 0.73
- MACD
- WKEY 0.25
- ALGS 0.03
- Stochastic Oscillator
- WKEY 57.80
- ALGS 68.35
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.